Clinical Pharmacokinetics of Amifostine and WR1065 in Pediatric Patients with Medulloblastoma

類似資料

• Amifostine Metabolite WR-1065 Disrupts Homologous Recombination in Mammalian Cells
  著者:: Dziegielewski, Jaroslaw, 等
  出版事項: (2010)
• Using plasma topotecan pharmacokinetics to estimate topotecan exposure in cerebrospinal fluid of children with medulloblastoma
  著者:: Freeman, Burgess B., 等
  出版事項: (2006)
• WR-1065, the Active Metabolite of Amifostine, Mitigates Radiation-Induced Delayed Genomic Instability
  著者:: Dziegielewski, Jaroslaw, 等
  出版事項: (2008)
• Amifostine Protects Against Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma
  著者:: Fouladi, Maryam, 等
  出版事項: (2008)
• Antiretroviral activity of aminothiols, WR2721 and WR1065
  著者:: Walker Dale M, 等
  出版事項: (2006-12-01)